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Leishmaniasis are parasitic diseases caused by a 
heteroxenous protozoan of the genus Leishmania (Ross 
1903). Leishmaniasis are complex diseases showing 
significant clinical pleomorphism and epidemiological 
diversity. The genus Leishmania is comprised of ap-
proximately 30 species, approximately 20 of which are 
pathogenic for humans (Desjeux 2004). 
Definitive diagnosis of cutaneous leishmaniasis (CL) 
can be challenging, especially in endemic areas where 
other diseases with similar clinical symptoms occur. 
The currently accepted gold standard for diagnosis re-
quires isolation of the parasites involved and microscop-
ic visualisation of amastigotes in tissue fragments from 
a lesion, though identification of the etiological agent at 
the species level is only possible if the parasite is suc-
cessfully cultured (Herwaldt 1999, Desjeux et al. 2004, 
Reithinger et al. 2007). 
The identification of Leishmania species in infect-
ed patients is crucial for achieving a correct prognosis 
and diagnosis (Arévalo et al. 2007). However, because 
of morphological similarities among the species of this 
genus, common parasitological assessments cannot dis-
criminate between them (Weigle et al. 1986, Wilson et al. 
1995, Aviles et al. 1999, Romero et al. 2001). Similarly, 
immunological tests, though useful for diagnosis, do not 
allow discrimination between Leishmania species.
Multilocus enzyme electrophoresis (MLEE) (Rioux 
et al. 1990), which is the gold standard for the identi-
fication of Leishmania species, requires prior isolation 
and mass culturing of the parasites. However, isolation 
can be complicated by the occurrence of secondary in-
fections and the protocol is costly and time consuming. 
Therefore, a method that ensures the direct diagnosis 
and identification of pathogenic Leishmania species is 
still required for an appropriate therapy to be developed, 
as well as to contribute to epidemiological studies.
The diversity of the species associated with human 
CL in Brazil further necessitates the development of a 
method for the diagnosis of CL and determination of 
pathogenic Leishmania species. In Brazil, there are two 
attributes of Leishmania braziliensis that warrant par-
ticular attention: (i) the species is widely distributed and 
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In this study, PCR assays targeting different Leishmania heat-shock protein 70 gene (hsp70) regions, producing 
fragments ranging in size from 230-390 bp were developed and evaluated to determine their potential as a tool for 
the specific molecular diagnosis of cutaneous leishmaniasis (CL). A total of 70 Leishmania strains were analysed, 
including seven reference strains (RS) and 63 previously typed strains. Analysis of the RS indicated a specific region 
of 234 bp in the hsp70 gene as a valid target that was highly sensitive for detection of Leishmania species DNA with 
capacity of distinguishing all analyzed species, after polymerase chain reaction-restriction fragment length poly-
morfism (PCR-RFLP). This PCR assay was compared with other PCR targets used for the molecular diagnosis of 
leishmaniasis: hsp70 (1400-bp region), internal transcribed spacer (ITS)1 and glucose-6-phosphate dehydrogenase 
(G6pd). A good agreement among the methods was observed concerning the Leishmania species identification. 
Moreover, to evaluate the potential for molecular diagnosis, we compared the PCR targets hsp70-234 bp, ITS1, 
G6pd and mkDNA using a panel of 99 DNA samples from tissue fragments collected from patients with confirmed 
CL. Both PCR-hsp70-234 bp and PCR-ITS1 detected Leishmania DNA in more than 70% of the samples. However, 
using hsp70-234 bp PCR-RFLP, identification of all of the Leishmania species associated with CL in Brazil can be 
achieved employing a simpler and cheaper electrophoresis protocol. 
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is often the sole or primary etiological agent of CL in 
several endemic areas and (ii) it is associated with the 
mucocutaneous form of the disease. However, this situ-
ation regarding Leishmania species is not static, as a 
few studies have revealed the presence of some species 
in areas where they had not previously been recorded 
(Azeredo-Coutinho et al. 2007, Azpurua et al. 2010, van 
Thiel et al. 2010), and other pathogenic species, such as 
Leishmania guyanensis, have been demonstrated to play 
an important role in the epidemiology of mucocutaneous 
leishmaniasis (Guerra et al. 2011).
Developing suitable detection methods for Leishma-
nia infections that also distinguish between the patho-
genic species involved has been a major challenge. Poly-
merase chain reaction (PCR)-based methods involving 
different targets have been proposed to enable charac-
terisation at the species level; these protocols have been 
tested in Leishmania promastigotes and for direct detec-
tion of the parasites in infected human or other animal 
tissues, including phlebotomine sandflies [see Reithinger 
and Dujardin (2007), Goto and Lindoso (2010), Schönian 
et al. (2011) for more details].
Whereas PCR assays targeted at amplification of 
internal transcribed spacer (ITS)1-rDNA are among 
the most commonly used methods for the diagnosis and 
identification of Leishmania species in the Old World 
(Schönian et al. 2010a), PCR targeted at amplification 
of the conserved locus of kDNA minicircles (mkDNA) 
has been widely used in Brazil (Ampuero et al. 2009). 
Digestion of the ITS1 amplicon using the restriction en-
zyme HaeIII has been demonstrated to be able to distin-
guish between nearly all Leishmania species, although 
distinction of some species, such as L. braziliensis and 
L. guyanensis, is only possible via sequence analysis of 
this region (Schönian et al. 2003). Few methods have 
been developed for the identification of specific species; 
one such protocol employs a PCR protocol that targets 
amplification of the glucose-6-phosphate dehydroge-
nase (G6pd) gene of L. braziliensis, which is the main 
etiological agent of mucocutaneous leishmaniasis in the 
Americas (Castilho et al. 2003).
A PCR-restriction fragment length polymorfism 
(RFLP) assay for the heat-shock protein 70 gene (hsp70) 
has recently been presented as a simple, universal tool 
for discrimination of Leishmania species in both the New 
and Old Worlds (Montalvo et al. 2010). This tool has been 
successfully used to distinguish human pathogenic Leish-
mania species circulating in Brazil (da Silva et al. 2010). 
Although this technique has already been used for direct 
diagnosis of CL (Garcia et al. 2004), the sensitivity of 
this assay is compromised by the large size (1400-bp) of 
the target region. Therefore, in this study, a region of the 
hsp70 gene of Leishmania spp was analysed and prim-
ers flanking regions ranging from 234-384 bp in length 
were designed for amplification of smaller fragments 
of this gene. The ability of these regions to distinguish 
between Leishmania species was assessed by digesting 
each PCR product with restriction enzymes. A panel of 
70 strains (including reference strains) of the Leishmania 
species circulating in Brazil was used for this purpose. 
In addition, the feasibility of this method was evaluated, 
including comparison with other PCR-based assays for 
the molecular diagnosis of CL using a panel of clinical 
samples from several endemic areas in Brazil.
SUBJECTS, MATERIALS AND METHODS
Leishmania strains - References strains of L. bra-
ziliensis, L. guyanensis, Leishmania naiffi, Leishmania 
shawi, Leishmania lainsoni, Leishmania amazonensis 
and Leishmania infantum, in addition to 63 other strains 
representative of these species, were used in this study (n 
= 70) (Table I). The stocks were frozen in liquid nitrogen 
and are part of the archive of the Leishmania Collection 
at the Oswaldo Cruz Institute (CLIOC); all of the strains 
were previously identified using MLEE. After thawing, 
the parasites were cultured in a two-phase culture medi-
um (NNN-Schneider) (Cupolillo et al. 1994). DNA from 
these strains was extracted using the WizardTM Genomic 
DNA Purification kit (Promega, WI, USA) according to 
the manufacturer’s instructions. The extracted DNA was 
quantified using a Nanodrop® spectrophotometer. 
Clinical samples - A total of 99 DNA samples from 
tissue fragments collected from patients with a con-
firmed diagnosis of CL were used in this study. Biop-
sies were performed by physicians as part of the routine 
procedure for the diagnosis of leishmaniasis, according 
to ethical protocols, including obtaining patient consent 
and approval from the respective ethics committees. A 
total of 50, 29 and 20 samples were used from patients 
who resided in the states of Acre (AC), Rio de Janeiro 
(RJ) and Mato Grosso, respectively (Table II).
The biopsies were frozen and stored at -20ºC prior 
to DNA extraction using the WizardTM Genomic DNA 
Purification kit according to the manufacturer’s in-
structions, which included a prior phase of digestion 
with proteinase K.
PCR and RFLP assays - New primers were designed 
for amplification of smaller fragments corresponding to 
regions of the hsp70 gene (Fig. 1, Table III). Primer de-
sign was accomplished via analysis of sequences from 
the Leishmania hsp70 gene [which were deposited in 
GenBank (GU071172.1 - GU071188.1)] using the Primer-
Blast tool available from the National Center for Biotech-
nology Information. Seven primers were designed (for-
ward: hsp70F1, hsp70F2, hsp70F3 and hsp70F4; reverse: 
hsp70R1, hsp70R2 and hsp70R3) and combined to am-
plify four different fragments: hsp70A (230 bp), hsp70B 
(384 bp), hsp70C (234 bp) and hsp70D (379 bp) (Fig. 
1, Table III). These regions were selected based on the 
inter-species polymorphisms. The PCR amplifications 
were performed in a final volume of 25 μL containing 
1 μL of DNA, 20 pmol of each primer, 200 μM dNTPs, 
1.5 mM MgCl2 and 1 U GoTaq
® DNA polymerase 
(M3005, Promega). The PCR assays used the follow-
ing amplification cycle: 94ºC for 5 min followed by 30 
cycles of 94ºC for 30 sec, 61ºC for 1 min and 72ºC for 3 
min and a final extension at 72ºC for 8 min.
PCR assays targeting different genomic DNA regions 
were performed using DNA extracted from promasti-
gotes of the Leishmania strains (Table I) employing 
the following, previously described, methods: (i) PCR 
amplification of the G6pd gene locus (PCR-G6pd) us-
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ing a combination of primers (Castilho et al. 2003, Tojal 
da Silva et al. 2006); (ii) PCR targeting the ITS1 rDNA 
gene (PCR-ITS1) (Schönian et al. 2003, Tojal da Silva et 
al. 2006), (iii) PCR targeting a 1400-bp fragment of the 
hsp70 gene from Leishmania (PCR-hsp70) (Garcia et al. 
2004, da Silva et al. 2010) and (iv) PCR targeting a 234-
bp region of the hsp70 gene (see above for details).
Four PCR protocols were applied to DNA extracted 
from tissue fragments collected from lesions of patients 
who were diagnosed with CL. PCR targeting the conserved 
region of the mkDNA (120-bp PCR-mkDNA) (Volpini et 
al. 2004) was used only for molecular diagnostics and not 
for species identification. PCR-G6pd, PCR-ITS1 and 234-
bp PCR-hsp70 were used as described above.
The PCR products obtained from the different as-
says were visualised after electrophoresis on a 6% 
polyacrylamide gel, either by silver staining using a 
specific kit (DNA Silver Staining, GE Healthcare, 17-
6000-30) or with ultraviolet light after being stained 
with ethidium bromide.
TABLE II
Detection and identification of Leishmania spp by different polymerase chain reaction (PCR)-based methods 




234 bp  
hsp70







(non-Lb) nb Geographic origin
1 + + Lb + Lb + + - 10 AC, RJ
2 + + Lb + Lb - + - 2 AC
3 + + Lb + Ln + + - 2 AC
4 + + Lg + Lg + + + 1 AC
5 + + Lg + Lg + + - 1 AC
6 + + Ls + Ls NP NP NP 1 MT
7 + + Lb - _ NP NP NP 3 MT
8 + + Lb + Lb - - - 15 AC, RJ
9 + + Lb + Lb + - - 1 AC
10 + + Lb + Lb NP NP NP 11 MT
11 + + La + La NP NP NP 1 MT
12 + + Ln/Ll + Ll - - + 1 AC
13 + + Ll + Ll + - - 1 AC
14 + + Ll + Ll - - - 5 AC
15 + + Ll + Ll - - + 4 AC
16 + + Ll + Ll NP NP NP 1 MT
17 + + Ll - - - - 2 AC
18 + + Ln + Ln - - - 2 AC
19 + + Ln + Ln + - + 1 RJ
20 + + Ln + Lb + - - 1 AC
21 + + Lb - - + + - 5 AC, RJ
22 + + Lb - - - - - 5 AC, RJ
23 + + Lb - - NP NP NP 3 MT
24 + - - + Ll + - - 1 AC
25 + - - - - - - - 1 AC
26 + - - + Lb + + - 1 RJ
27 + - - + Lb - - - 8 AC, RJ
28 + - - - - + + - 1 RJ
29 + - - - - - - - 6 AC, RJ
30 - + Lb - - - - - 1 RJ
31 - + Lb + Lb - - - 1 RJ
Total 97 81 - 72 - 26 24 7 99 -
a: see Subjects, Materials and Methods for details; b: total of samples presenting this result; AC: Acre; hsp: heat-shock protein; 
ITS: internal transcribed spacer; La: Leishmania amazonensis; Lb: Leishmania braziliensis; Lg: Leishmania guyanensis; Ll: 
Leishmania lainsoni; Ln: Leishmania naiffi; Ls: Leishmania shawi; L(V): L. (Viannia); MT: Mato Grosso; NP: not performed; 
RFLP: restriction fragment length polymorphism; RJ: Rio de Janeiro; +: positive PCR; -: negative PCR. Samples presenting 
discordant species identification results were highlighted in bold.
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The PCR products from the amplification of ITS1 and 
hsp70 (1400 bp or smaller) were subjected to digestion 
with restriction enzymes. For G6pd-PCR, a combina-
tion of subgenus or species-specific primers was used for 
identification of strains according to previously described 
protocols (Castilho et al. 2003, Tojal da Silva et al. 2006). 
The objective was to identify the subgenus and if the sub-
genus was L. (Viannia), to identify L. braziliensis.
The restriction enzyme Sau3AI was used for diges-
tion of the ITS1 product based on previous results from 
our group (unpublished observations). HaeIII, MboI and 
BstUI were used to digest the products of amplifications 
that targeted hsp70 (da Silva et al. 2010). The amplifica-
tion products for hsp70A, hsp70B, hsp70C and hsp70D 
from the reference strains were subjected to digestion 
with HaeIII, MboI, BccI, RsaI, AvaI, BstuI, KpnI and 
SphI. Based on the results obtained, only HaeIII and 
BstuI were used to digest the products amplified (with 
hsp70C as the target) from DNA extracted from other 
samples. The digestion reactions with different restric-
tion enzymes were performed according to the manu-
facturer’s instructions. All of the enzymes used in this 
study were from New England BioLabs.
The obtained restriction products were electrophore-
sed on a 6% polyacrylamide gel, followed by silver 
staining using a specific kit, with the exception of ITS1, 
which was electrophoresed in a specific machine (Gene-
Phor electrophoresis unit, GE Healthcare) using a high-
resolution gel (GeneGel Excel 12.5/24 kit, GE Health-
care) and the same silver-staining kit mentioned above.
Molecular identification of the Leishmania strains 
using DNA from promastigotes was performed as a 
blind assay, without prior knowledge of the identity de-
termined via MLEE.
TABLE III
Primers used for amplification of different regions of the hsp70 gene




hsp70A (230 bp hsp70) 230 bp GCAAGGACGAGATCGAGCGCA 59.6 61.9
TCCTTCGACGCCTCCTGGTTG 58.2 61.9
hsp70B (384 bp hsp70) 384 bp ACAACCGCCTCGTCACGTTCT 58.7 57.1
TGTTCAGCTCCTTGCCGCCG 59.9 65
hsp70C (234 bp hsp70) 234 bp GGA CGAGATCGAGCGCATGGT 59.7 61.9
TCCTTCGACGCCTCCTGGTTG 58.5 61.9
hsp70D (379 bp hsp70) 379 bp CCGCCTCGTCACGTTCTTCAGC 60.3 63.6
GTTCAGCTCCTTGCCGCCGA 59.7 65
GC: guanine-cytosine; hsp: heat-shock protein; PCR: polymerase chain reaction; Tm: melting temperature.
Fig. 1: position of polymerase chain reaction products from different primer combinations in relation to the heat-shock protein (hsp)70 gene 
on chromosome 28 of Leishmania major [strain Friedlin (ncbi.nlm.nih.gov) accession FR796424 CT005266]. hsp70A: 230 bp; hsp70B: 384 bp; 
hsp70C: 234 bp; hsp70D: 379 bp.
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A fragment of hamster tissue that was not infected 
with Leishmania was included as a negative control dur-
ing the extraction of each clinical sample. A no DNA 
negative control was included in each PCR run.
As a positive control, a reaction containing DNA 
extracted from tissue fragments of a hamster that had 
been experimentally infected with L. amazonensis was 
included in each PCR run.
To avoid sample contamination, separate worksta-
tions were used to extract DNA from the promastigotes 
and clinical samples, to prepare the master mix solution 
for the addition of DNA to the master mix and to verify 
the amplicons via electrophoresis.
Sequencing - The products obtained for the hsp70C 
(234 bp) target from reference strains were visualised on 
a 2% agarose gel and purified using the Wizard SV Gel 
kit and PCR Clean-up System kit (Promega). The prod-
ucts were then sequenced with the same primers used 
for the PCR assay. Sequencing was performed on an 
automated sequencer (ABI PRISM® BigDye™ Termina-
tor Cycle Sequencing) at the facilities of Oswaldo Cruz 
Foundation (IOC) (Genomic Platform - DNA sequenc-
ing, PDTIS-FIOCRUZ). 
Statistical analysis - The number of positive clinical 
samples was calculated as a percentage using the results 
obtained for the different molecular markers evaluated 
in this study for detection of Leishmania DNA.
The Kappa index was used to determine the agreement 
between the results obtained for each molecular marker 
evaluated in the study (ITS1, G6pd and 234-bp hsp70). 
This calculation was performed using the software avail-
able at lee.dante.br/pesquisa/kappa/index.html.
The sensitivity of each method was determined based 
on comparison with the results of the PCR-mkDNA as-
say, which was considered as the gold standard because 
of its high sensitivity for CL diagnosis. 
RESULTS
Identification of Leishmania spp reference strains - 
PCR-RFLP of the ITS-1 product using Sau3AI differenti-
ated between the analysed Leishmania species, although 
it was possible to distinguish between L. guyanensis and 
L. braziliensis only when electrophoresis of the digested 
product was performed on a high-resolution gel (Fig. 2).
PCR-RFLP of the 1400-bp hsp70 region differenti-
ated between all of the species when BstUI, MboI and 
HaeIII were used, which supported the findings of pre-
vious studies (da Silva et al. 2010). The results could be 
visualised by electrophoresis using either a high-resolu-
tion gel or a 6% polyacrylamide gel (results not shown).
Neither PCR-hsp70B nor PCR-hsp70D were useful for 
identification of the Leishmania species. The same pro-
files were observed for all of the species analysed, wheth-
er PCR-RFLP of the hsp70B or the hsp70D targets was 
employed, with any of the restriction enzymes tested.
The assessment of the different hsp70 fragments re-
vealed that PCR-hsp70C and PCR-hsp70A yielded iden-
tical results (i.e., the same RFLP profile), reflecting the 
fact that the primers for hsp70A and hsp70C are targeted 
at flanking or neighbouring regions (Fig. 1). PCR-RFLP 
of either hsp70A or hsp70C discriminated between all of 
the analysed Leishmania species when a maximum of 
three restriction enzymes (HaeIII, MboI and BstUI) were 
used. HaeIII generated identical profiles for L. lainsoni 
and L. shawi as well as for L. braziliensis and L. naiffi, 
whereas L. guyanensis, L. amazonensis and L. infantum 
exhibited unique profiles. BstUI differentiated L. naiffi 
from L. braziliensis and L. shawi from L. lainsoni; these 
species could also be differentiated using MboI (Fig. 3). 
Because the same result was achieved via PCR-RFLP 
of either hsp70 A or C, the PCR hsp70C product (234 bp) 
for all of the reference strains was sequenced to determine 
whether it matched the expected region of the hsp70 gene 
(Fig. 1). Sequence analysis revealed that this fragment cor-
responded to the region of the gene between base pairs 
1545-1778, which is a portion of the hsp70 gene on chro-
mosome 28 of Leishmania major [strain Friedlin (ncbi.nlm.
nih.gov) accession FR796424 CT005266]. The sequences 
obtained were identical to a portion of the hsp70 gene (re-
gion between sites 1346-1580) that was already deposited 
in GenBank for the same strains sequenced in the pres-
ent study (L. naiffi: GU071183.1; L. shawi: GU071177.1; 
L. lainsoni: GU071174.1; L. braziliensis: GU071173.1; L. 
guyanensis: GU071172.1; L. amazonensis: EU599090.1), 
with polymorphisms observed between species. 
Validation of species identification assays - All of the 
strains (Table I) were included in a blind assay to assess 
the reliability of the various targets for discriminating 
between Leishmania species.
The results of ITS1 PCR-RFLP validated the MLEE 
identification, with one exception. The PCR-RFLP pro-
files for the 1400-bp hsp70 and 234-bp hsp70 fragments 
from the different Leishmania species were repeated for 
the panel assembled with 63 strains and the identifica-
tion obtained at the species level supported the MLEE 
results, although six exceptions were observed for the 
1400-bp hsp70 PCR-RFLP (Table I).
Strain identification was also confirmed by the 
PCR-G6pd results, although this technique only dis-
criminated between the subgenera L. (Leishmania) and 
L. (Viannia) and, within the latter, between L. brazilien-
sis and non-L. braziliensis.
Fig. 2: internal transcribed spacer 1 polymerase chain reaction-re-
striction fragment length polymorphism profiles of different Leish-
mania species after digestion of products with Sau3AI. A: panel of 
profiles for reference strains; B: pattern for the sample RB004 from 
a patient diagnosed with cutaneous leishmaniasis, exhibiting a mixed 
profile between the species Leishmania lainsoni (Ll) and Leismania 
naiffi (Ln). Silver-stained 12.5% polyacrylamide gel (Genephor®). bp: 
50 bp molecular weight marker; La: Leishmania amazonensis; Lb: 
Leishmania braziliensis; Lg: Leishmania guyanensis; Li: Leishmania 
infantum; Ls: Leishmania shawi.
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Discrepancies were only observed for seven strains 
(Table I). Strain IOC/L1731, which was characterised 
by MLEE as L. braziliensis, exhibited an L. guyanensis 
profile when ITS1 PCR-RFLP was used and a non-L. 
braziliensis profile when PCR-G6pd was used, although 
the 1400-bp hsp70 and 234-bp hsp70C PCR-RFLP re-
sults validated the MLEE identification. Strains L2492 
and L2498, which were characterised as L. braziliensis 
by MLEE and ITS1 PCR-RFLP, showed a non-L. bra-
ziliensis profile when PCR-G6pd was used and a L. 
naiffi profile when 1400-bp hsp70 PCR-RFLP was used. 
Strains L2495, L2499 and L2501, which were character-
ised as L. braziliensis by MLEE, ITS1 PCR-RFLP, PCR-
G6pd and 234-bp hsp70C PCR-RFLP, each presented an 
L. naiffi profile when 1400-bp hsp70 PCR-RFLP was 
used. Finally, strain L2493, which was characterised 
as L. guyanensis by MLEE and most of the molecular 
methods employed in this study, was positive in all of 
the G6pd PCR assays tested, meaning that it could not be 
identified as L. braziliensis or non-L. braziliensis.
Sensitivity of PCR methods for the diagnosis of leish-
maniasis and the identification of Leishmania species 
in clinical samples - The DNA used in these assays was 
isolated from tissue fragments collected from cutane-
ous lesions of patients who had been diagnosed with CL 
based on clinical examination, parasitological analysis 
and/or their therapeutic response (Table II). High DNA 
concentrations can inhibit PCR and the DNA extracted 
from clinical samples can contain an amount of patient 
DNA that is much higher than the quantity of DNA from 
Leishmania; therefore, it is critical to determine the 
maximum DNA concentration to be used in each PCR 
assay. Although the effect of the concentration of human 
DNA on the PCR results was not evaluated in this study, 
quantities equal to or greater than 20 ng hindered the 
amplification of the target DNA (unpublished observa-
tions). Consequently, 200 pg of total DNA (from human 
tissue) per reaction was used.
Only two of the 99 samples analysed were negative 
for PCR-mkDNA (98% positivity), so this assay was con-
sidered to be the gold standard for determination of the 
sensitivity of the other PCR assays. The positivity was 
81.8% (81/99) for PCR-ITS1, 41.8% (33/79) for PCR-g6p 
and 72.7% (72/99) for PCR-hsp70-234 bp. PCR-G6pd 
was not performed for samples from MT because suffi-
cient DNA was not available. Both samples negative for 
kDNA were positive for ITS1; only one was positive for 
hsp70-234 bp and both were negative for g6p (Table II).
Of the 99 samples analysed, 62 were positive for ITS1 
and hsp70-234 bp and only eight were negative for both 
targets. A total 19 of samples were positive for ITS1 alone 
and 10 were positive for hsp70-234 bp alone. The agree-
ment between the PCR-ITS1 and PCR-hsp70-234 bp results 
was low according to the Kappa index (Kappa = 0.176, p 
= 0.071). Combining the two assays (PCR-ITS1 and PCR-
hsp70-234 bp), 91.9% (91/99) positivity was achieved.
The sensitivities of PCR-ITS1, PCR-hsp70-234 bp 
and PCR-G6pd were 81.4% (79/97), 73.2% (71/97) and 
41.6% (32/77), respectively, compared with the mkD-
NA PCR assay.
Whether clinical samples for which amplification 
products were obtained in every PCR assay could be dif-
ferentiated at the species level depended on the target, as 
observed with the cultured strains (Table I). ITS1 PCR-
RFLP allowed identification of the various Leishmania 
species in the clinical samples, as follows (number of 
samples in parentheses): L. braziliensis (58), L. lainsoni 
(13), L. guyanensis (2), L. naiffi (2), L. shawi (1), L. ama-
zonensis (1) and one sample with a mixed profile between 
L. lainsoni and L. naiffi (Fig. 2). PCR-G6pd identified 
samples infected with L. braziliensis (22) vs. non-L. bra-
ziliensis (6). Finally, hsp70-234 bp PCR-RFLP identified 
the following parasite species in the samples: L. brazil-
iensis (50), L. lainsoni (13), L. naiffi (5), L. guyanensis 
(2), L. shawi (1) and L. amazonensis (1).
Regarding species identification in the 62 samples that 
were positive for both PCR-ITS1 and PCR-hsp70-234 bp, 
Fig. 3: 234 bp heat-shock protein 70 (hsp70C) polymerase chain reaction-restriction fragment length polymorphism profiles for reference strains 
of different Leishmania species after digestion of products with BstUI, HaeIII and MboI. Silver-stained 12.5% polyacrylamide gel (Genephor®). 
La: Leishmania amazonensis; Lb: Leishmania braziliensis; Lg: Leishmania guyanensis; Li: Leishmania infantum; Ll: Leishmania lainsoni; Ln: 
Leishmania naiffi; Ls: Leishmania shawi; 100 bp: molecular weight marker.
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only four samples yielded conflicting results, which are 
presented below. Twenty-three samples were identified 
by ITS1 PCR-RFLP, PCR-hsp70-234 bp and PCR-G6pd 
(Table II). Eighteen samples yielded consistent results. 
Two samples (RB005 and RB011) yielded conflicting re-
sults and were characterised as L. braziliensis by ITS1 
PCR-RFLP and PCR-G6pd, but as L. naiffi by hsp70-234 
bp PCR-RFLP. One sample (RB053) was characterised 
as L. naiffi by ITS1 PCR-RFLP, but as L. braziliensis by 
hsp70-234 bp PCR-RFLP; this sample was positive for 
PCR-G6pd, which distinguished the subgenus L. (Vian-
nia). Sample RB004 was characterised as L. lainsoni by 
hsp70-234 bp PCR-RFLP, but as non-L. braziliensis by 
PCR-G6pd, whereas the ITS1 PCR-RFLP profile sug-
gested a combination between L. lainsoni and L. naiffi 
(Fig. 2). These results could indicate either combined in-
fection by L. naiffi and L. lainsoni or a hybrid between 
these two species, as a combined infection would not ex-
plain the hybrid profile observed with MLEE.
Sample RB013 demonstrated a L. guyanensis profile 
based on ITS1 PCR-RFLP and hsp70C PCR-RFLP, but 
was positive in all PCR-G6pd assays, thereby precluding 
identification of this sample as L. braziliensis or non-L. 
braziliensis using this methodology. Strain IOC/L2493 
was isolated from sample RB013 and was characterised 
as L. guyanensis based on all of the markers (Table I). 
However, after analysis of the L. (Viannia) strains with a 
battery of microsatellites, strain IOC/L2493 was includ-
ed in the same cluster as Leishmania panamensis and L. 
shawi (Oddone et al. 2009).
DISCUSSION
The main objective of this study was to develop a 
PCR-based method that can be used for diagnosis of CL, 
to both the infection and allowing identification of the 
species involved. Previous research indicates that PCR-
RFLP of a 1400-bp fragment of the Leishmania hsp70 
gene can differentiate all of the species circulating in 
Brazil. Through analysis of 70 strains, the present study 
validated the previously demonstrated ability of this 
methodology to discriminate between the various Leish-
mania species associated with human leishmaniasis in 
Brazil (da Silva et al. 2010). This portion of the hsp70 
gene has also been used in other studies and its potential 
to distinguish Leishmania species has been discussed. 
Furthermore, the effectiveness of this target for molecu-
lar diagnosis of leishmaniasis has previously been sug-
gested (Garcia et al. 2004, 2007, Fraga et al. 2010). 
However, given the large size of the 1400-bp hsp70 
fragment, a lower level of success is expected for this 
target when amplifying small amounts of DNA, such 
as those obtained from clinical samples. Therefore, new 
primers were designed to amplify smaller fragments 
of the Leishmania hsp70 gene. A 234-bp region of the 
Leishmania hsp70 gene (designated 234-bp PCR-hsp70 
in this study) was deemed promising, given its utility for 
detecting and identifying Leishmania species in clinical 
samples. The ability of several PCR assays, either follow-
ing an RFLP approach or not, to discriminate between 
species was evaluated using a panel of reference strains 
representing the Leishmania species circulating in Brazil. 
Although 120-bp mkDNA PCR-RFLP has been demon-
strated to be appropriate for identifying some Leishmania 
species (Volpini et al. 2004), this approach was not used 
in the present study because most of the species analysed 
here belong to the L. (Viannia) subgenus and a conserved 
region would be not appropriate for distinguishing be-
tween closely related species. Furthermore, profile repro-
ducibility and identification of Leishmania species using 
mkDNA PCR-RFLP could be hindered by variability in 
the minicircle classes (Brewster & Barker 2002). ITS1 
PCR-RFLP using Sau3AI generated the same profiles as 
are obtained with HaeIII (E Cupolillo, unpublished obser-
vations), which has been used in several studies employ-
ing ITS1 PCR-RFLP to diagnose leishmaniasis (Schönian 
et al. 2003, Nasereddin et al. 2008, Gelanew et al. 2010, 
Hajjaran et al. 2011). As reported elsewhere, the differ-
ences between L. braziliensis and L. guyanensis are not 
easily detected, although there are polymorphisms in the 
DNA sequences of both species. Therefore, high-resolu-
tion gel electrophoresis, which can resolve fragment size 
differences as small as 4 bp, was successfully employed to 
distinguish between these two species.
A total of 63 strains were used to validate the iden-
tification of Leishmania species from different PCR-
RFLP and PCR-G6pd assays. Notably, the panel of 
isolates, which represented the diversity of the genus 
Leishmania, demonstrated the risk of using only refer-
ence strains for evaluating the ability of a method to 
discriminate between species, considering the observed 
disagreement in the identification of some strains based 
on the different methods.
Profile reproducibility was satisfactory for ITS1 PCR-
RFLP, 234-bp hsp70 PCR-RFLP and PCR-G6pd among 
the assayed strains, though there were a few exceptions. 
The target associated with the most conflicting results 
compared with MLEE was 1400-bp hsp70 PCR-RFLP, 
while 234-bp hsp70 PCR-RFLP corroborated the MLEE 
identification for all of the evaluated strains. Some 
strains characterised as L. braziliensis by MLEE pre-
sented a non-L. braziliensis profile for PCR-g6p. These 
strains exhibited an atypical electromorphic profile for 
the g6PDH enzyme, which was different from the profile 
observed for the reference strains and the vast majority 
of strains that were characterised as L. braziliensis (Cu-
polillo et al. 1994, 1995). This result corroborates recent 
data obtained by our group, which indicate the presence 
of different alleles for the G6pd gene among L. brazi-
liensis strains (unpublished observations). These find-
ings should be considered prior to employing this type of 
PCR analysis in samples collected from regions where L. 
braziliensis variants have already been described.
Discrepancies among the results related to the identi-
fication of Leishmania species were also observed when 
using clinical samples and the possibility that there were 
mixed infections among the specimens cannot be ruled 
out (Camara-Coelho et al. 2011). One explanation for this 
finding is the differential amplification of each marker, 
whereby different primers may preferentially amplify 
DNA from different species. 
It has previously been reported that Leishmania 
strains from various species might exhibit similar pro-
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files, depending on the marker used (Almeida et al. 2011). 
For the subgenus L. (Viannia), this is expected because 
the species from this group show high genetic similarity 
(Cupolillo et al. 1995, 1997, Cupolillo & Momen 2000), 
share epitopes (Grimaldi & MacMahon-Pratt 1996) and 
exhibit high similarity among partial sequences of cer-
tain genes (Croan et al. 1997, Asato et al. 2009, Fraga et 
al. 2010). Moreover, the mechanisms of genetic recom-
bination have been described for natural populations of 
Leishmania (Rougeron et al. 2010). 
To assess the potential of different targets for molecu-
lar diagnosis of leishmaniasis, including species discrimi-
nation, the ITS1, G6pd and 234-bp hsp70 regions were 
employed. The capacity to detect Leishmania spp was 
compared with the PCR-mkDNA results. Although em-
ploying PCR-RFLP mkDNA for species identification ap-
pears to be inappropriate (see above), the high sensitivity 
of this method justifies its use for the molecular diagnosis 
of leishmaniasis (Pereira et al. 2008, Ampuero et al. 2009, 
Romero et al. 2009, Kobets et al. 2010, Azmi et al. 2011).
The targets with the highest positive rates were 120-
bp mkDNA-PCR, followed by ITS1-PCR, 234-bp hsp70-
PCR and G6pd-PCR. A better performance for mkDNA-
PCR compared with ITS1-PCR has also been observed 
in previous studies (Bensoussan et al. 2006, Azmi et 
al. 2011). This result was expected because primer sets 
that target sequences with higher copy numbers in the 
genome will be more sensitive. mkDNA PCR has been 
considered to represent an excellent alternative for the 
molecular diagnosis of leishmaniasis because of its 
high sensitivity, given the approximately 10,000-20,000 
minicircles per Leishmania cell (Simpson 1973). Many 
copies of the ribosomal gene have been observed per 
Leishmania diploid genome. For example, the presence 
of 20-40 copies per cell has been reported for L. (Vian-
nia) species (Inga et al. 1998). In at least some Leish-
mania species, the hsp70 genes are arranged in a single 
genomic cluster that contains five or six HSP70-I copies 
followed by one HSP70-II copy (Ramirez et al. 2011), 
whereas g6p is a single-copy gene.
Amplification of the ITS1-PCR and 234-bp hsp70-
PCR DNA fragments yielded approximately 17% agree-
ment between the genes. Several studies comparing the 
use of PCR-based assays for molecular diagnosis of leish-
maniasis have demonstrated poor agreement between 
different methods applied to the same samples (Marfurt 
et al. 2003, Azmi et al. 2011), but the cause of this dispar-
ity has not been established. Discrepant results obtained 
from different PCR assays can be explained by various 
factors, such as an unequal distribution of DNA in solu-
tion (Chandler 1998). Furthermore, although the primers 
used in this study were designed to amplify conserved 
regions, there could be failures in the annealing of the 
primer sequence with the target DNA, thereby hamper-
ing amplification by PCR. Moreover, the presence of a 
secondary infection with other microorganisms (such as 
fungi and bacteria) in leishmaniasis lesions is common 
(Formiga et al. 1986, Edrissian et al. 1990, Vera et al. 
2001, Markle & Makhoul 2004, Bhutto et al. 2009). Some 
primers may share similarities with DNA sequences of 
these microorganisms, thus affecting PCR performance. 
ITS1 PCR-RFLP and 234-bp hsp70 PCR-RFLP 
yielded the best results because these methods differ-
entiate between etiological agents at the species level. 
These findings confirmed the circulation of L. bra-
ziliensis, L. lainsoni and L. guyanensis in AC (Tojal 
da Silva et al. 2006) and suggested the presence of L. 
naiffi in this region. Although a strain showing a hy-
brid profile between L. lainsoni and L. naiffi had previ-
ously been isolated, the latter species had not yet been 
identified in this region (Tojal da Silva et al. 2006). As 
expected, only L. braziliensis was observed in patients 
from RJ (de Oliveira-Neto et al. 2000) and the single 
sample characterised as L. naiffi was isolated from a 
patient who had been infected in the Amazon. L. bra-
ziliensis, L. amazonensis, L. shawi and L. lainsoni were 
found in samples from MT and the first two species 
have previously been reported in this region (Carvalho 
et al. 2006). To our knowledge, there are no existing 
reports of L. shawi and L. lainsoni in MT. Analysing 
the records of the patient infected with L. lainsoni, it 
was noted that he was most likely infected in an area 
where this Leishmania species is circulating (AC) (To-
jal da Silva et al. 2006). The patient infected with L. 
shawi acquired the infection in MT, in a region that is 
north of the state, an area of occurrence of the Amazon 
Rain Forest. Although the aim of this analysis was not 
to determine which species are circulating the studied 
regions (AC, RJ and MT), the results indicate the im-
portance of combining diagnosis with the identification 
of species for the surveillance of leishmaniasis.
The discrimination of Leishmania species should 
be addressed to understand the discrepancies among 
the various markers. The biological species concept 
cannot be applied to Leishmania and there is current-
ly no agreement regarding the definition of the spe-
cies boundaries within this genus (Banuls et al. 1999, 
Schönian et al. 2010b). Therefore, none of the available 
genotyping systems can currently serve as the gold 
standard for the identification of a particular species 
and a combination of different methods is required. 
However, the use of different protocols is impractical 
and may be unnecessary when the objective is to com-
bine molecular diagnosis with the identification of an 
etiological agent or to assist in epidemiological surveil-
lance, prognosis and definition of therapeutic regimens. 
ITS1 PCR-RFLP delivered promising results and other 
studies have demonstrated that this assay performs well 
for the identification of Leishmania species circulat-
ing in the Old World (Schönian et al. 2003, Bensoussan 
et al. 2006, Shahbazi et al. 2008). However, the find-
ing that it was only possible to distinguish between L. 
braziliensis and L. guyanensis via sequencing or high-
resolution gel electrophoresis limits the utility of ITS1 
PCR-RFLP in the areas where these species occur. The 
234-bp hsp70 PCR-RFLP assay, which targeted a region 
of the Leishmania hsp70 gene, combined the ability to 
detect Leishmania in clinical samples with the ability 
to discriminate between all of the species circulating 
in Brazil, which could make this technique particularly 
useful in areas of sympatry.
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